COVID-19 Impact on Global Targeted Biomarker Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Targeted Biomarker Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Targeted Biomarker Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Safety biomarker
  • 1.4.3 Efficacy biomarker
  • 1.4.4 Validation biomarker
• 1.5 Market by Application
  • 1.5.1 Global Targeted Biomarker Market Share by Application: 2020 VS 2026
  • 1.5.2 Diagnostics development
  • 1.5.3 Drug discovery & development
  • 1.5.4 Personalized medicine
  • 1.5.5 Disease risk assessment
  • 1.5.6 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Targeted Biomarker Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Targeted Biomarker Industry
    • 1.6.1.1 Targeted Biomarker Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Targeted Biomarker Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Targeted Biomarker Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Targeted Biomarker Market Perspective (2015-2026)
• 2.2 Targeted Biomarker Growth Trends by Regions
  • 2.2.1 Targeted Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Targeted Biomarker Historic Market Share by Regions (2015-2020)
  • 2.2.3 Targeted Biomarker Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Targeted Biomarker Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Targeted Biomarker Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Targeted Biomarker Players by Market Size
  • 3.1.1 Global Top Targeted Biomarker Players by Revenue (2015-2020)
  • 3.1.2 Global Targeted Biomarker Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Targeted Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Targeted Biomarker Market Concentration Ratio
  • 3.2.1 Global Targeted Biomarker Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Targeted Biomarker Revenue in 2019
• 3.3 Targeted Biomarker Key Players Head office and Area Served
• 3.4 Key Players Targeted Biomarker Product Solution and Service
• 3.5 Date of Enter into Targeted Biomarker Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Targeted Biomarker Historic Market Size by Type (2015-2020)
• 4.2 Global Targeted Biomarker Forecasted Market Size by Type (2021-2026)

5 Targeted Biomarker Breakdown Data by Application (2015-2026)

• 5.1 Global Targeted Biomarker Market Size by Application (2015-2020)
• 5.2 Global Targeted Biomarker Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Targeted Biomarker Market Size (2015-2020)
• 6.2 Targeted Biomarker Key Players in North America (2019-2020)
• 6.3 North America Targeted Biomarker Market Size by Type (2015-2020)
• 6.4 North America Targeted Biomarker Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Targeted Biomarker Market Size (2015-2020)
• 7.2 Targeted Biomarker Key Players in Europe (2019-2020)
• 7.3 Europe Targeted Biomarker Market Size by Type (2015-2020)
• 7.4 Europe Targeted Biomarker Market Size by Application (2015-2020)

8 China

• 8.1 China Targeted Biomarker Market Size (2015-2020)
• 8.2 Targeted Biomarker Key Players in China (2019-2020)
• 8.3 China Targeted Biomarker Market Size by Type (2015-2020)
• 8.4 China Targeted Biomarker Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Targeted Biomarker Market Size (2015-2020)
• 9.2 Targeted Biomarker Key Players in Japan (2019-2020)
• 9.3 Japan Targeted Biomarker Market Size by Type (2015-2020)
• 9.4 Japan Targeted Biomarker Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Targeted Biomarker Market Size (2015-2020)
• 10.2 Targeted Biomarker Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Targeted Biomarker Market Size by Type (2015-2020)
• 10.4 Southeast Asia Targeted Biomarker Market Size by Application (2015-2020)

11 India

• 11.1 India Targeted Biomarker Market Size (2015-2020)
• 11.2 Targeted Biomarker Key Players in India (2019-2020)
• 11.3 India Targeted Biomarker Market Size by Type (2015-2020)
• 11.4 India Targeted Biomarker Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Targeted Biomarker Market Size (2015-2020)
• 12.2 Targeted Biomarker Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Targeted Biomarker Market Size by Type (2015-2020)
• 12.4 Central & South America Targeted Biomarker Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 bioMerieux
  • 13.1.1 bioMerieux Company Details
  • 13.1.2 bioMerieux Business Overview and Its Total Revenue
  • 13.1.3 bioMerieux Targeted Biomarker Introduction
  • 13.1.4 bioMerieux Revenue in Targeted Biomarker Business (2015-2020))
  • 13.1.5 bioMerieux Recent Development
• 13.2 IntegraGen
  • 13.2.1 IntegraGen Company Details
  • 13.2.2 IntegraGen Business Overview and Its Total Revenue
  • 13.2.3 IntegraGen Targeted Biomarker Introduction
  • 13.2.4 IntegraGen Revenue in Targeted Biomarker Business (2015-2020)
  • 13.2.5 IntegraGen Recent Development
• 13.3 Myriad Genetics
  • 13.3.1 Myriad Genetics Company Details
  • 13.3.2 Myriad Genetics Business Overview and Its Total Revenue
  • 13.3.3 Myriad Genetics Targeted Biomarker Introduction
  • 13.3.4 Myriad Genetics Revenue in Targeted Biomarker Business (2015-2020)
  • 13.3.5 Myriad Genetics Recent Development
• 13.4 Protagen
  • 13.4.1 Protagen Company Details
  • 13.4.2 Protagen Business Overview and Its Total Revenue
  • 13.4.3 Protagen Targeted Biomarker Introduction
  • 13.4.4 Protagen Revenue in Targeted Biomarker Business (2015-2020)
  • 13.4.5 Protagen Recent Development
• 13.5 Qiagen
  • 13.5.1 Qiagen Company Details
  • 13.5.2 Qiagen Business Overview and Its Total Revenue
  • 13.5.3 Qiagen Targeted Biomarker Introduction
  • 13.5.4 Qiagen Revenue in Targeted Biomarker Business (2015-2020)
  • 13.5.5 Qiagen Recent Development
• 13.6 PerkinElmer
  • 13.6.1 PerkinElmer Company Details
  • 13.6.2 PerkinElmer Business Overview and Its Total Revenue
  • 13.6.3 PerkinElmer Targeted Biomarker Introduction
  • 13.6.4 PerkinElmer Revenue in Targeted Biomarker Business (2015-2020)
  • 13.6.5 PerkinElmer Recent Development
• 13.7 Merck Millipore
  • 13.7.1 Merck Millipore Company Details
  • 13.7.2 Merck Millipore Business Overview and Its Total Revenue
  • 13.7.3 Merck Millipore Targeted Biomarker Introduction
  • 13.7.4 Merck Millipore Revenue in Targeted Biomarker Business (2015-2020)
  • 13.7.5 Merck Millipore Recent Development
• 13.8 Bio-Rad Laboratories
  • 13.8.1 Bio-Rad Laboratories Company Details
  • 13.8.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
  • 13.8.3 Bio-Rad Laboratories Targeted Biomarker Introduction
  • 13.8.4 Bio-Rad Laboratories Revenue in Targeted Biomarker Business (2015-2020)
  • 13.8.5 Bio-Rad Laboratories Recent Development
• 13.9 Enzo Biochem
  • 13.9.1 Enzo Biochem Company Details
  • 13.9.2 Enzo Biochem Business Overview and Its Total Revenue
  • 13.9.3 Enzo Biochem Targeted Biomarker Introduction
  • 13.9.4 Enzo Biochem Revenue in Targeted Biomarker Business (2015-2020)
  • 13.9.5 Enzo Biochem Recent Development
• 13.10 EKF Diagnostics
  • 13.10.1 EKF Diagnostics Company Details
  • 13.10.2 EKF Diagnostics Business Overview and Its Total Revenue
  • 13.10.3 EKF Diagnostics Targeted Biomarker Introduction
  • 13.10.4 EKF Diagnostics Revenue in Targeted Biomarker Business (2015-2020)
  • 13.10.5 EKF Diagnostics Recent Development
• 13.11 Meso Scale Diagnostics, LLC.
  • 10.11.1 Meso Scale Diagnostics, LLC. Company Details
  • 10.11.2 Meso Scale Diagnostics, LLC. Business Overview and Its Total Revenue
  • 10.11.3 Meso Scale Diagnostics, LLC. Targeted Biomarker Introduction
  • 10.11.4 Meso Scale Diagnostics, LLC. Revenue in Targeted Biomarker Business (2015-2020)
  • 10.11.5 Meso Scale Diagnostics, LLC. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer